Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 U.S.C. 379g Definitions
21 U.S.C. 379g Definitions, “Definitions”, is a U.S. Code section of Subpart 2—fees relating to drugs; in force.
https://ontology.bommaritollc.com/id/01a0f06c-cd9b-757d-8d10-2b57a60676da
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 U.S.C. 379g |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Definitionsen |
| schema:url | |
| skos:prefLabel | 21 U.S.C. 379g Definitionsen |
Related
Cited by (9)eli:cites
- 21 U.S.C. 360bbb-4a Priority review to encourage treatments for agents that present national security threats
- 21 U.S.C. 360ff Priority review to encourage treatments for rare pediatric diseases
- 21 U.S.C. 360n Priority review to encourage treatments for tropical diseases
- 21 U.S.C. 379h Authority to assess and use drug fees
- 21 U.S.C. 379h-1 Fees relating to advisory review of prescription-drug television advertising
- 21 U.S.C. 379j-11 Definitions
- 21 U.S.C. 379j-21 Authority to assess and use generic new animal drug fees
- 21 U.S.C. 379j-52 Authority to assess and use biosimilar biological product fees
- 21 U.S.C. 379j-61 Definitions